Free Trial

Klotho Neurosciences (KLTO) Competitors

Klotho Neurosciences logo
$1.23 -0.04 (-3.15%)
As of 04:00 PM Eastern

KLTO vs. IMMP, TRDA, ESPR, DSGN, NBTX, PRQR, TVRD, TKNO, FENC, and ACIU

Should you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Prima BioMed (IMMP), Entrada Therapeutics (TRDA), Esperion Therapeutics (ESPR), Design Therapeutics (DSGN), Nanobiotix (NBTX), ProQR Therapeutics (PRQR), Tvardi Therapeutics (TVRD), Alpha Teknova (TKNO), Adherex Technologies (FENC), and AC Immune (ACIU). These companies are all part of the "pharmaceutical products" industry.

Klotho Neurosciences vs. Its Competitors

Prima BioMed (NASDAQ:IMMP) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

Prima BioMed has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500. Comparatively, Klotho Neurosciences has a beta of 11.08, suggesting that its stock price is 1,008% more volatile than the S&P 500.

In the previous week, Klotho Neurosciences had 4 more articles in the media than Prima BioMed. MarketBeat recorded 5 mentions for Klotho Neurosciences and 1 mentions for Prima BioMed. Prima BioMed's average media sentiment score of 1.87 beat Klotho Neurosciences' score of 0.63 indicating that Prima BioMed is being referred to more favorably in the media.

Company Overall Sentiment
Prima BioMed Very Positive
Klotho Neurosciences Positive

Prima BioMed currently has a consensus price target of $7.00, indicating a potential upside of 306.98%. Given Prima BioMed's stronger consensus rating and higher possible upside, equities analysts plainly believe Prima BioMed is more favorable than Klotho Neurosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prima BioMed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Klotho Neurosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

2.3% of Prima BioMed shares are held by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are held by institutional investors. 3.1% of Prima BioMed shares are held by insiders. Comparatively, 26.7% of Klotho Neurosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Klotho Neurosciences has lower revenue, but higher earnings than Prima BioMed.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prima BioMed$5.14M48.87-$28.01MN/AN/A
Klotho NeurosciencesN/AN/A-$6.15M-$0.36-3.42

Prima BioMed's return on equity of 0.00% beat Klotho Neurosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Prima BioMedN/A N/A N/A
Klotho Neurosciences N/A -1,779.01%-275.01%

Summary

Prima BioMed beats Klotho Neurosciences on 7 of the 12 factors compared between the two stocks.

Get Klotho Neurosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KLTO vs. The Competition

MetricKlotho NeurosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$58.49M$2.50B$5.70B$9.51B
Dividend YieldN/A1.75%4.69%4.01%
P/E Ratio-3.429.0528.0720.05
Price / SalesN/A757.64448.5799.42
Price / CashN/A165.2136.2258.56
Price / Book30.755.168.665.87
Net Income-$6.15M$30.99M$3.25B$258.55M
7 Day Performance-4.65%7.74%4.20%2.23%
1 Month Performance-1.60%16.18%10.82%12.76%
1 Year PerformanceN/A-1.03%34.70%19.36%

Klotho Neurosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KLTO
Klotho Neurosciences
N/A$1.23
-3.1%
N/AN/A$58.49MN/A-3.42N/A
IMMP
Prima BioMed
1.4938 of 5 stars
$1.70
-0.6%
$7.00
+311.8%
-19.0%$248.27MN/A0.002,021News Coverage
Positive News
Upcoming Earnings
TRDA
Entrada Therapeutics
3.5255 of 5 stars
$6.38
+3.9%
$25.67
+302.3%
-60.5%$242.12M$210.78M7.88110
ESPR
Esperion Therapeutics
3.8097 of 5 stars
$1.22
+6.1%
$7.00
+473.8%
-36.3%$241.80M$259.57M-1.52200
DSGN
Design Therapeutics
0.5584 of 5 stars
$4.25
+4.9%
$4.00
-5.9%
-15.5%$241.27MN/A-4.2940Positive News
NBTX
Nanobiotix
1.6198 of 5 stars
$5.09
-0.4%
$8.00
+57.2%
+22.0%$239.89M$39.18M0.00100News Coverage
Gap Up
PRQR
ProQR Therapeutics
2.8831 of 5 stars
$2.28
-2.6%
$8.00
+250.9%
+20.2%$239.88M$20.46M-6.51180
TVRD
Tvardi Therapeutics
N/A$25.37
-2.0%
$64.25
+153.3%
N/A$237.46M$7.14M0.0080
TKNO
Alpha Teknova
2.2219 of 5 stars
$4.42
+7.5%
$10.00
+126.2%
+58.1%$236.21M$37.74M-9.21240News Coverage
Analyst Upgrade
FENC
Adherex Technologies
2.5177 of 5 stars
$8.52
+1.3%
$13.00
+52.6%
+32.7%$235.15M$30.91M-16.7110Gap Up
ACIU
AC Immune
2.0697 of 5 stars
$2.31
+11.1%
$12.00
+419.5%
-31.2%$231.95M$28.30M-3.98140Positive News

Related Companies and Tools


This page (NASDAQ:KLTO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners